Inhalation therapy in asthma: nebulizer or pressurized metered-dose inhaler with holding chamber? In vivo comparison of lung deposition in children

J Pediatr. 1999 Jul;135(1):28-33. doi: 10.1016/s0022-3476(99)70323-9.

Abstract

Objective: To compare lung deposition from a nebulizer and a pressurized metered-dose inhaler (pMDI)/holding chamber to determine their efficiency in aerosol delivery to children.

Study design: Children with stable asthma (n = 17) aged 2 to 9 years inhaled in random order radiolabeled salbutamol from a nebulizer and a pMDI through a nonstatic holding chamber. Body and lung deposition of radiolabeled salbutamol was assessed with a gamma camera.

Results: Mean (absolute dose) total lung deposition expressed as a percentage of the nebulized dose was 5.4% (108 microg) in younger children (<4 years) and 11.1% (222 microg) in older children (>4 years). Mean (absolute dose) total lung deposition expressed as a percentage of the metered dose was 5.4% (21.6 microg) in younger and 9.6% (38.4 microg) in older children.

Conclusions: For the same age groups we have shown equivalent percentages of total lung deposition of radiolabeled salbutamol aerosolized by either a nebulizer or a pMDI/holding chamber. However, the delivery rate per minute and the total dose of salbutamol deposited were significantly higher for the nebulizer.

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Albuterol / administration & dosage*
  • Analysis of Variance
  • Asthma / drug therapy*
  • Bronchodilator Agents / administration & dosage*
  • Child
  • Child, Preschool
  • Humans
  • Infant
  • Lung / chemistry*
  • Nebulizers and Vaporizers*
  • Radionuclide Imaging

Substances

  • Bronchodilator Agents
  • Albuterol